Penserra Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,791
| Closed | -$445K | – | 1513 |
|
|
2021
Q4 | $445K | Sell |
4,791
-1,400
| -23% | -$130K | 0.01% | 544 |
|
|
2021
Q3 | $368K | Sell |
6,191
-75,014
| -92% | -$4.46M | 0.01% | 550 |
|
|
2021
Q2 | $5.54M | Sell |
81,205
-21,504
| -21% | -$1.47M | 0.1% | 249 |
|
|
2021
Q1 | $7.13M | Buy |
102,709
+72,030
| +235% | +$5M | 0.13% | 183 |
|
|
2020
Q4 | $2.36M | Sell |
30,679
-1,805
| -6% | -$139K | 0.06% | 249 |
|
|
2020
Q3 | $2.43M | Buy |
32,484
+28,569
| +730% | +$2.14M | 0.09% | 203 |
|
|
2020
Q2 | $246K | Buy |
3,915
+435
| +13% | +$27.3K | 0.01% | 457 |
|
|
2020
Q1 | $146K | Hold |
3,480
| – | – | 0.01% | 494 |
|
|
2019
Q4 | $165K | Buy |
3,480
+876
| +34% | +$41.5K | 0.01% | 490 |
|
|
2019
Q3 | $119K | Buy |
+2,604
| New | +$119K | 0.01% | 519 |
|